CLN5 抗体 (AA 140-220)
Our Local Distributor
北京 101111
Quick Overview for CLN5 抗体 (AA 140-220) (ABIN7219404)
抗原
See all CLN5 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 140-220
-
原理
- CLN5 Polyclonal Antibody
-
特异性
- CLN5 Polyclonal Antibody detects endogenous levels of CLN5 protein.
-
纯化方法
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
免疫原
- Synthesized peptide derived from the Internal region of human CLN5 at AA range: 140-220
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:10000). Not yet tested in other applications.
-
说明
-
Primary Antibody
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- CLN5 (Ceroid-Lipofuscinosis, Neuronal 5 (CLN5))
-
别名
- CLN5
-
背景
- Rabbit Anti-CLN5 Polyclonal Antibody,CLN5, Ceroid-lipofuscinosis neuronal protein 5, Protein CLN5,CLN5 is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.,Ceroid-lipofuscinosis neuronal protein 5
-
分子量
- observerd band 48kDa
-
基因ID
- 1203
-
UniProt
- O75503
抗原
-